Coronary flow during rapid heart rates

  • Research type

    Research Study

  • Full title

    Coronary epicardial and microcirculatory determinants of ventricular tachycardia tolerability

  • IRAS ID

    319116

  • Contact name

    Ricardo Petraco

  • Contact email

    r.petraco@imperial.ac.uk

  • Sponsor organisation

    Imperial College London

  • Duration of Study in the UK

    3 years, 0 months, 2 days

  • Research summary

    Ventricular tachycardia (VT) is a common and life-threatening arrhythmia that occurs in people with heart problems. Same patients who develop this arrhythmia remain very stable with very little symptoms while others become unstable with low blood pressure or even sudden death. It is not known why some people tolerate the arrhythmia well and others do not.

    If VT is not tolerated then current practice is to offer an implantable cardioverter defibrillator (ICD) which can deliver a shock to the heart if dangerous heart rhythms are detected. While shocks can be life-saving, they are also harmful, including causing psychological distress. ICDs also frequently deliver shocks when they are not needed. If we could identify which factors predispose a person to be stable or unstable in VT, this would allow doctors to help them in a range of ways. One way would be to treat them to improve their tolerance of VT, so avoiding the need for an ICD. Another would be to assess the their risk of instability and so allow a patient-centred decision on whether an ICD is needed.

    In this study we plan to recruit patients who are referred to have a coronary angiogram. During their angiogram we will stimulate the heart at a range of fast heart rates and measure their blood pressure and flow in their coronary arteries. In patients who undergo stenting for a coronary stenosis, we will also make these measurements after stenting so we can can see if there is any difference. By recruiting a range of different cardiology patients we will be able to assess which factors contribute to stability during VT. In order to assess coronary flow during clinical VT we will also recruit patients having an ablation procedure for VT.

  • REC name

    London - Camden & Kings Cross Research Ethics Committee

  • REC reference

    23/LO/0162

  • Date of REC Opinion

    25 Apr 2023

  • REC opinion

    Further Information Favourable Opinion